Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Ten-eleven translocation (TET) proteins are implicated in various cancers due to abnormal expression.
• Understanding TET protein function in osteosarcoma is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression pattern of TET proteins in osteosarcoma cells.
• To determine the effect of TET1 on cell apoptosis, cell cycle, and proliferation.
• To explore the relationship between TET1, 5-hydroxymethylcytosine (5hmC) levels, and osteosarcoma progression.

Main Methods:

• Osteosarcoma U2OS cells were treated with hydroxyurea.
• TET1 expression, cell apoptosis, and cell cycle were analyzed.
• 5-methylcytosine (5mC) and 5hmC levels were quantified.
• TET1 knockdown and overexpression experiments were performed.

Main Results:

• Hydroxyurea treatment upregulated TET1 expression and increased 5hmC levels in U2OS cells.
• Hydroxyurea also induced cell apoptosis and altered the cell cycle.
• Overexpression of TET1 enhanced cell apoptosis and inhibited cell proliferation.
• Knockdown of TET1 showed opposite effects on cell growth and apoptosis.

Conclusions:

• TET1 expression plays a significant role in regulating proliferation and apoptosis in osteosarcoma cells.
• The observed effects are associated with changes in 5hmC levels, suggesting an epigenetic regulatory mechanism.
• TET1 may serve as a potential therapeutic target for osteosarcoma treatment.